Chronic Schizophrenia Clinical Trial
Official title:
Nintendo Wii and Schizophrenia. A Pilot Study.
Verified date | February 2016 |
Source | Queen's University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
The purpose of this study is to determine whether the use of Nintendo Wii will help improve negative symptoms of Schizophrenia and quality of life of patients with chronic Schizophrenia.
Status | Completed |
Enrollment | 5 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Patients diagnosed with Schizophrenia defined by the DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision) - Males or females aged 18 years of older - Participate in the Community High Intensity Treatment Team (CHITT) out-patient program - Certified by their physician to participate in physical activity Exclusion Criteria: - History of violence or other risks that may endanger study research assistants during home visits |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | Community High Intensity Treatment Team (CHITT) at Providence Care Mental Health Services | Kingston | Ontario |
Lead Sponsor | Collaborator |
---|---|
Queen's University | Walmart Canada Corporation |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of life. | To assess whether any benefit in daily functioning and quality of life can be gained from using the Nintendo Wii video game console in people with chronic Schizophrenia. Assessed with the use of Short Form (36 questions)self report Health Survey (SF-36), Global Assessment of Functioning (GAF) Scale and the Clinical Global Impression-Schizophrenia(CGI-SCH)Scale. | 6 months | No |
Secondary | Weight. | To assess whether the use of Nintendo Wii will help in weight reduction [assessed using Body Mass Index (BMI) calculations and weight measurements] in patients with Chronic Schizophrenia. | 6 months | No |
Secondary | Subjective overall functioning. | To assess whether the use of Nintendo Wii will help to: reduce cigarette consumption, improve subjective quality of life and motivation [assessed using a self report Visual Analog Scale(VAS)] in patients with Chronic Schizophrenia. | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00161044 -
An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms
|
N/A | |
Completed |
NCT01450514 -
POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia
|
Phase 2 | |
Completed |
NCT05809882 -
Study of Experience of High-frequency Repetitive Transcranial
|
N/A | |
Recruiting |
NCT05948696 -
Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia
|
||
Completed |
NCT06206798 -
Resourcefulness Group Intervention on Recovery and Quality of Life
|
N/A | |
Completed |
NCT01891929 -
Cognitive Remediation and Sheltered Employment in Schizophrenia
|
N/A | |
Completed |
NCT03275909 -
Integrated Psychological Therapy for Chronic Schizophrenia
|
N/A | |
Completed |
NCT02298985 -
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
|
Phase 4 | |
Recruiting |
NCT00525863 -
Oxygen Therapy in Schizophrenia
|
Phase 3 | |
Completed |
NCT02624167 -
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
|
Phase 2 | |
Completed |
NCT00789698 -
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
|
Phase 3 | |
Recruiting |
NCT06349369 -
Effect of tDCS on Inflammatory Biomarkers in Chronic Schizophrenia
|
N/A | |
Completed |
NCT02421146 -
The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study
|
N/A | |
Active, not recruiting |
NCT00664274 -
Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia
|
N/A | |
Terminated |
NCT00148616 -
Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia
|
Phase 3 |